Baird Says Time is Right to Own NewLink Genetics (NLNK)
Get Alerts NLNK Hot Sheet
Price: $0.89 --0%
Rating Summary:
1 Buy, 4 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 11
Rating Summary:
1 Buy, 4 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 11
Join SI Premium – FREE
Baird reiterated an Outperform rating on NewLink Genetics (NASDAQ: NLNK) and raised its price target to $20.00 (from $17.00).
"Though the quarterly print was uneventful, we continue to like NLNK for its significant pipeline potential, with first HyperAcute Pancreas Phase III interim look in early-2013 – an event that we think brings real un-modeled upside potential as our base case assumes a 2015 approval," said analyst Christopher J. Raymond.
He thinks the stock recent 15 percent pullback offers a compelling entry point in front of the pivotal HyperAcute data next year.
For an analyst ratings summary and ratings history on NewLink Genetics click here. For more ratings news on NewLink Genetics click here.
Shares of NewLink Genetics closed at $13.81 yesterday.
"Though the quarterly print was uneventful, we continue to like NLNK for its significant pipeline potential, with first HyperAcute Pancreas Phase III interim look in early-2013 – an event that we think brings real un-modeled upside potential as our base case assumes a 2015 approval," said analyst Christopher J. Raymond.
He thinks the stock recent 15 percent pullback offers a compelling entry point in front of the pivotal HyperAcute data next year.
For an analyst ratings summary and ratings history on NewLink Genetics click here. For more ratings news on NewLink Genetics click here.
Shares of NewLink Genetics closed at $13.81 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SoundThinking (SSTI) PT Lowered to $8 at Cantor Fitzgerald
- Liberty Media Corp-Liberty Formula One (FWONA) PT Raised to $124 at Guggenheim
- Liberty Formula One (FWONK) PT Raised to $134 at Guggenheim
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS View, Analyst PT ChangeRelated Entities
Robert W BairdSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share